{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:47:56Z","timestamp":1782906476228,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.7759\/cureus.111873","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:09:35Z","timestamp":1782904175000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed Myelin Oligodendrocyte Glycoprotein Antibody-Associated Demyelination Five Years After an Acute Disseminated Encephalomyelitis-Like Episode in an Adolescent: A Case Report"],"prefix":"10.7759","author":[{"given":"Hind","family":"Zahiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Elouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeladim","family":"Babakhouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rkain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell B","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al.. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023, 22:268-82. 10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51759","article-title":"Attack phenotypes and disease course in pediatric MOGAD","volume":"10","author":"Santoro JD","year":"2023","unstructured":"Santoro JD, Beukelman T, Hemingway C, Hokkanen SR, Tennigkeit F, Chitnis T. Attack phenotypes and disease course in pediatric MOGAD. Ann Clin Transl Neurol. 2023, 10:672-85. 10.1002\/acn3.51759","journal-title":"Ann Clin Transl Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8089","article-title":"Clinical and imaging findings in children with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): from presentation to relapse","volume":"45","author":"George E","year":"2024","unstructured":"George E, Russ JB, Validrighi A, et al.. Clinical and imaging findings in children with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): from presentation to relapse. AJNR Am J Neuroradiol. 2024, 45:229-35. 10.3174\/ajnr.A8089","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-333464","article-title":"Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"96","author":"Virupakshaiah A","year":"2024","unstructured":"Virupakshaiah A, Schoeps VA, Race J, et al.. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024, 96:68-75. 10.1136\/jnnp-2024-333464","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"E.U. paediatric MOG consortium consensus: part 5 - treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens AL","year":"2020","unstructured":"Bruijstens AL, Wendel EM, Lechner C, et al.. E.U. paediatric MOG consortium consensus: part 5 - treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020, 29:41-53. 10.1016\/j.ejpn.2020.10.005","journal-title":"Eur J Paediatr Neurol"},{"key":"ref6","unstructured":"Aids to the examination of the peripheral nervous system. (1976). Accessed. July 1, 2026: https:\/\/www.ukri.org\/wp-content\/uploads\/2021\/12\/MRC-011221-AidsToTheExaminationOfThePeripheralNervousSystem.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl M","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019, 15:89-102. 10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor JY","year":"2023","unstructured":"Hor JY, Fujihara K. Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. 2023, 14:1260358. 10.3389\/fneur.2023.1260358","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: part 1 - classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens AL","year":"2020","unstructured":"Bruijstens AL, Lechner C, Flet-Berliac L, et al.. E.U. paediatric MOG consortium consensus: part 1 - classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020, 29:2-13. 10.1016\/j.ejpn.2020.10.006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105672","article-title":"Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"87","author":"Rempe T","year":"2024","unstructured":"Rempe T, Rodriguez E, Elfasi A, et al.. Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024, 87:105672. 10.1016\/j.msard.2024.105672","journal-title":"Mult Scler Relat Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01825-1","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients","volume":"17","author":"Jarius S","year":"2020","unstructured":"Jarius S, Lechner C, Wendel EM, et al.. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients. J Neuroinflammation. 2020, 17:262. 10.1186\/s12974-020-01825-1","journal-title":"J Neuroinflammation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231166834","article-title":"Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS","volume":"29","author":"Redenbaugh V","year":"2023","unstructured":"Redenbaugh V, Chia NH, Cacciaguerra L, et al.. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Mult Scler. 2023, 29:799-808. 10.1177\/13524585231166834","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2025.04.012","article-title":"French guidelines for the diagnosis and management of MOG antibody-associated disease","volume":"181","author":"Giorgi L","year":"2025","unstructured":"Giorgi L, Marignier R, Pique J, et al.. French guidelines for the diagnosis and management of MOG antibody-associated disease. Rev Neurol (Paris). 2025, 181:597-607. 10.1016\/j.neurol.2025.04.012","journal-title":"Rev Neurol (Paris)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurad.2024.101235","article-title":"MRI management of NMOSD and MOGAD: proposals from the French Expert Group NOMADMUS","volume":"52","author":"Durand-Dubief F","year":"2025","unstructured":"Durand-Dubief F, Shor N, Audoin B, et al.. MRI management of NMOSD and MOGAD: proposals from the French Expert Group NOMADMUS. J Neuroradiol. 2025, 52:101235. 10.1016\/j.neurad.2024.101235","journal-title":"J Neuroradiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.11.001","article-title":"E.U. paediatric MOG consortium consensus: part 3 - biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Armangue T","year":"2020","unstructured":"Armangue T, Capobianco M, de Chalus A, Laetitia G, Deiva K. E.U. paediatric MOG consortium consensus: part 3 - biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020, 29:22-31. 10.1016\/j.ejpn.2020.11.001","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494017-delayed-myelin-oligodendrocyte-glycoprotein-antibody-associated-demyelination-five-years-after-an-acute-disseminated-encephalomyelitis-like-episode-in-an-adolescent-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:09:44Z","timestamp":1782904184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494017-delayed-myelin-oligodendrocyte-glycoprotein-antibody-associated-demyelination-five-years-after-an-acute-disseminated-encephalomyelitis-like-episode-in-an-adolescent-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.111873","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}